Cognitive Precision Medicine
Researchers at the BSC Life Sciences Department have collaborated with IBM Research Zurich in a joint effort to put text analytics at the forefront of biomedical research in melanoma, the deadliest form of skin cancer. Thanks to MelanomaMine, a text mining application developed at BSC that uses machine learning to extract melanoma-specific information, operations of the IBM Watson cognitive computing system were enabled to provide insights into melanoma healthcare. In particular, by coupling MelanomaMine and IBM Watson, the researchers identified relevant gene-to-phenotype associations that could be used to inform melanoma risk assessment.
-